Krystal Biotech, Inc. KRYS Accrued rebates
Accrued rebates at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:IncreaseDecreaseInAccruedRebates.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s accrued rebates.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s accrued rebates?
- Krystal Biotech, Inc. (KRYS) reported accrued rebates of $12.69M in Q1 2026.
- How has Krystal Biotech, Inc.'s accrued rebates changed year-over-year?
- Krystal Biotech, Inc.'s accrued rebates increased by 19.7% year-over-year, from $10.6M to $12.69M.
- What does accrued rebates mean?
- The change in the estimated amount of rebates the company expects to pay out.
- How do you interpret accrued rebates?
- An increase suggests higher projected sales volume or changes in rebate programs, while a decrease indicates the settlement of these obligations.
- How does accrued rebates compare across companies?
- Highly specific to pharmaceutical and consumer goods companies with complex pricing and rebate structures.